Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Amplify Bitcoin 2% Monthly Option Income ETF
Atour Lifestyle Holdings Limited - American Depositary Shares
Cecors Inc
Cenovus Energy Inc Common Stock
DEFSEC Technologies Inc. - common stock, no R/S concurrent with offering
DatChat, Inc. - Common Stock
Fidelity Digital Health ETF
Infineon Techs Ag
Ishares Core MSCI All Cntry Ex Can ETF
NanoViricides, Inc. Common Stock
Netcapital Inc. - Common Stock
Nxt Energy Solutions Inc
Oxford Lane Capital Corp. - Closed End Fund
Resona Holdings Inc
SCYNEXIS, Inc. - Common Stock
Silver Range Resources Ltd
Viking Holdings Ltd
Voyageur Pharmaceuticals Ltd
Wartsila Corp
Edit Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Veradermics, Incorporated Common Stock
(NY:
MANE
)
138.86
-1.86 (-1.32%)
Delayed Quote
Updated: 12:39 PM EDT, Oct 28, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Veradermics, Incorporated Common Stock
Why This Hair Restoration Biotech's Shares Are Soaring
↗
October 25, 2026
Veradermics' shares are up nearly 270% since its IPO earlier this year.
Via
The Motley Fool
Topics
Initial Public Offering
Veradermics Phase III Hair Loss Trial Meets All Endpoints, Posts Strong Growth Results
↗
October 19, 2026
Veradermics (NYSE:MANE) reported positive top-line results from Part A of Study 304, its second Phase III trial of VDPHL01, an extended-release oral minoxidil tablet being developed for men with mild...
Via
MarketBeat
Veradermics Hair Loss Pill Shows Strong Phase II Signal in Women
↗
July 15, 2026
Veradermics (NYSE:MANE) said results from the female arms of Study 207, a phase II open-label trial of VDPHL01 for mild to moderate pattern hair loss, showed what company executives described as a...
Via
MarketBeat
This Fund Has a $75 Million Bet on a Hair Loss Biotech Stock Up More Than 500% Post-IPO
↗
May 14, 2026
Veradermics develops novel dermatology treatments, targeting both adult and pediatric markets with a research-driven approach.
Via
The Motley Fool
Topics
Initial Public Offering
These stocks are moving in today's session
↗
April 27, 2026
Via
Chartmill
Top stock movements in today's session.
↗
April 27, 2026
Via
Chartmill
These stocks are gapping in today's session
↗
April 27, 2026
Via
Chartmill
Top movers in Monday's pre-market session
↗
April 27, 2026
Via
Chartmill
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.